Brief: Ironwood Pharmaceuticals Reports Strong Q3 Results Maintains Full Year 2022 Financial Guidance

Ironwood Pharmaceuticals

03/11/2022 11:22

Nov 3 (Reuters) - Ironwood Pharmaceuticals Inc  IRWD.O :
    * IRONWOOD PHARMACEUTICALS REPORTS STRONG THIRD QUARTER 2022
RESULTS; MAINTAINS FULL YEAR 2022 FINANCIAL GUIDANCE
    * TOTAL REVENUES IN Q3 OF 2022 WERE $108.6 MILLION, COMPARED
TO
$103.7 MILLION IN Q3 OF 2021.
    * TOTAL REVENUES IN Q3 OF 2022 WERE $108.6 MILLION, COMPARED
TO
$103.7 MILLION IN Q3 OF 2021.
    * IRONWOOD PHARMACEUTICALS- NON-GAAP NET INCOME WAS $50.2
MILLION,
OR $0.33 PER SHARE (BASIC) AND $0.28 PER SHARE (DILUTED), IN Q3
OF 2022
    * REITERATES 2022 GUIDANCE OF U.S. LINZESS NET SALES GROWTH
OF LOW
SINGLE DIGITS %,
    * GAAP NET INCOME. GAAP NET INCOME WAS $50.3 MILLION, OR
$0.33 PER
SHARE (BASIC) AND $0.28 PER SHARE (DILUTED), IN Q3 OF 2022
    * Q3 EARNINGS PER SHARE VIEW $0.27, REVENUE VIEW $109.4
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw98l9hta 
Further company coverage:  IRWD.O 
 ((Reuters.Briefs@thomsonreuters.com;))